Related Experiment Video
Updated: Jan 8, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Castleman disease mimicking prostate cancer metastasis: diagnostic implications of [68Ga]Ga-PSMA-11 PET/CT
Wioletta Chalewska1, Paulina Cegla2, Klaudia Zajkowska1
1Department of Endocrine Oncology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Abstract:
Castleman's disease is a rare lymphoproliferative disorder that can mimic malignancy in cancer patients. This study presents a rare case of Castleman disease coexisting with prostate cancer, highlighting the potential value of gallium 68-labelled prostate-specific membrane antigen-11 ([⁶⁸Ga]Ga-PSMA-11) positron emission tomography/computed tomography (PET/CT) in distinguishing Castleman disease from prostate cancer metastasis.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
08:55A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...